This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Biagini, R. E.
Right arrow Articles by Quinn, C. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Biagini, R. E.
Right arrow Articles by Quinn, C. P.

 Previous Article  |  Next Article 

Clinical and Vaccine Immunology, May 2006, p. 541-546, Vol. 13, No. 5
1071-412X/06/$08.00+0     doi:10.1128/CVI.13.5.541-546.2006

Rapid, Sensitive, and Specific Lateral-Flow Immunochromatographic Device To Measure Anti-Anthrax Protective Antigen Immunoglobulin G in Serum and Whole Blood

Raymond E. Biagini,1* Deborah L. Sammons,1 Jerome P. Smith,1 Barbara A. MacKenzie,1 Cynthia A. F. Striley,1 John E. Snawder,1 Shirley A. Robertson,1 and Conrad P. Quinn2

Biological Monitoring Laboratory Section, Biomonitoring and Health Assessment Branch, National Institute for Occupational Safety and Health (NIOSH), Centers for Disease Control and Prevention, Cincinnati, Ohio,1 Microbial Pathogenesis and Immune Response (MPIR) Laboratory, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia2

Received 26 January 2006/ Returned for modification 1 March 2006/ Accepted 13 March 2006

Evidence from animals suggests that anti-anthrax protective antigen (PA) immunoglobulin G (IgG) from vaccination with anthrax vaccine adsorbed (AVA) is protective against Bacillus anthracis infection. Measurement of anti-PA IgG in human sera can be performed using either enzyme-linked immunosorbent assay or fluorescent covalent microsphere immunoassay (ELISA) (R. E. Biagini, D. L. Sammons, J. P. Smith, B. A. MacKenzie, C. A. Striley, V. Semenova, E. Steward-Clark, K. Stamey, A. E. Freeman, C. P. Quinn, and J. E. Snawder, Clin. Diagn. Lab. Immunol. 11:50-55, 2004). Both these methods are laboratory based. We describe the development of a rapid lateral-flow immunochromatographic assay (LFIA) test kit for the measurement of anti-PA IgG in serum or whole-blood samples (30-µl samples) using colloidal gold nanoparticles as the detection reagent and an internal control. Using sera from 19 anthrax AVA vaccinees (anti-PA IgG range, 2.4 to 340 µg/ml) and 10 controls and PA-supplemented whole-blood samples, we demonstrated that the LFIA had a sensitivity of approximately 3 µg/ml anti-PA IgG in serum and ~14 µg/ml anti-PA IgG in whole blood. Preabsorption of sera with PA yielded negative anti-PA LFIAs. The diagnostic sensitivity and specificity of the assay were 100% using ELISA-measured anti-PA IgG as the standard. This kit has utility in determining anti-PA antibody reactivity in the sera of individuals vaccinated with AVA or individuals with clinical anthrax.


* Corresponding author. Mailing address: Division of Applied Research and Technology, Biomonitoring and Health Assessment Branch, Biological Monitoring Research Team, CDC/NIOSH MS C-26, Robert A. Taft Laboratories, 4676 Columbia Parkway, Cincinnati, OH 45226. Phone: (513) 533-8196. Fax: (513) 533-8494. E-mail: rbiagini{at}cdc.gov.


Clinical and Vaccine Immunology, May 2006, p. 541-546, Vol. 13, No. 5
1071-412X/06/$08.00+0     doi:10.1128/CVI.13.5.541-546.2006




This article has been cited by other articles:

  • Tang, S., Moayeri, M., Chen, Z., Harma, H., Zhao, J., Hu, H., Purcell, R. H., Leppla, S. H., Hewlett, I. K. (2009). Detection of Anthrax Toxin by an Ultrasensitive Immunoassay Using Europium Nanoparticles. CVI 16: 408-413 [Abstract] [Full Text]  
  • Bienek, D. R., Biagini, R. E., Charlton, D. G., Smith, J. P., Sammons, D. L., Robertson, S. A. (2008). Rapid Point-of-Care Test To Detect Broad Ranges of Protective Antigen-Specific Immunoglobulin G Concentrations in Recipients of the U.S.-Licensed Anthrax Vaccine. CVI 15: 644-649 [Abstract] [Full Text]